PRESS RELEASE
21 October 2025

Mintz Advises The Placement Agents In Spruce Biosciences, Inc.’s $50 Million Private Placement

M
Mintz

Contributor

Mintz is a litigation powerhouse and business accelerator serving leaders in life sciences, private equity, sustainable energy, and technology. The world’s most innovative companies trust Mintz to provide expert advice, protect and monetize their IP, negotiate deals, source financing, and solve complex legal challenges. The firm has over 600 attorneys across offices in Boston, Los Angeles, Miami, New York, Washington, DC, San Francisco, San Diego, and Toronto.
Mintz advised the placement agents in connection with Spruce Biosciences, Inc.'s $50 million private placement. The investors purchased common stock...
United States

Mintz advised the placement agents in connection with Spruce Biosciences, Inc.'s $50 million private placement. The investors purchased common stock (and pre-funded warrants in lieu of common stock for certain investors).

Leerink Partners, Citizens Capital Markets, and H.C. Wainwright & Co. acted as placement agents for the financing. Oppenheimer & Co. acted as capital markets advisor for the financing.

The Mintz capital markets team included William Hicks, John Rudy, Nishant Dharia, Sam Silver, Gianna Nappi, Kate McLeod, and Nicole Gaston. Joanne Hawana advised as to regulatory matters.

Contributor

Mintz is a litigation powerhouse and business accelerator serving leaders in life sciences, private equity, sustainable energy, and technology. The world’s most innovative companies trust Mintz to provide expert advice, protect and monetize their IP, negotiate deals, source financing, and solve complex legal challenges. The firm has over 600 attorneys across offices in Boston, Los Angeles, Miami, New York, Washington, DC, San Francisco, San Diego, and Toronto.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More